Article
Zavegepant intranasal spray for the Acute Treatment of Migraine : A Systematic Review and Meta-Analysis of Randomized Clinical Trials
2023-08-02
Abstract excerpt
<title>Abstract</title> <p>Migraine is a prevalent and debilitating primary headache disorder with significant socio-economic and personal impacts. This study aims to evaluate the safety and efficacy of zavegepant, a recently approved third-generation small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray (BHV-3500), ), to be administered as a nasal spray in the acute treatment of m...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5af5c21f-62fb-5200-bf19-3f2fe9ff2fc1
- DOI
- 10.21203/rs.3.rs-3215981/v1
